Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-०.२१%
१,०९१.५१
-२.३०
-०.२१%
—१,०९३.८११,०९६.५२१,१००.२२१,०९१.५१——
SIXC
Communications
SIXC
Communications
SIXC
+०.२२%
६१०.११
+१.३४
+०.२२%
—६०८.७७६०८.७७६१२.९७६०८.७७——
SIXE
Energy
SIXE
Energy
SIXE
-१.३४%
१,२३७.९८
-१६.८३
-१.३४%
—१,२५४.८११,२५३.०११,२५३.८७१,२२६.३३——
SIXI
Industrials
SIXI
Industrials
SIXI
-०.९३%
१,७४४.७१
-१६.४०
-०.९३%
—१,७६१.१११,७६४.२७१,७६६.८८१,७४४.७१——
SIXM
Financials
SIXM
Financials
SIXM
-०.३७%
६४०.१८
-२.४०
-०.३७%
—६४२.५८६४४.८७६४८.४८६४०.१८——
SIXR
Staples
SIXR
Staples
SIXR
-०.१८%
८४९.५८
-१.५५
-०.१८%
—८५१.१३८५५.६६८५८.७५८४५.५६——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-०.२३%
२१७.४८
-०.५०
-०.२३%
—२१७.९८२१७.९८२१८.६५२१६.८८——
SIXT
Technology
SIXT
Technology
SIXT
+१.५२%
३,२६०.६९
+४८.८६
+१.५२%
—३,२११.८३३,२२७.२१३,२६८.३८३,२२६.५५——
SIXU
Utilities
SIXU
Utilities
SIXU
-०.६९%
९४२.४५
-६.५३
-०.६९%
—९४८.९८९४८.५८९५७.८३९४१.९७——
SIXV
Health care
SIXV
Health care
SIXV
-०.५२%
१,४६६.८०
-७.७२
-०.५२%
—१,४७४.५२१,४७९.०३१,४८१.०४१,४६६.८०——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+०.२२%
२,३९७.५०
+५.३८
+०.२२%
—२,३९२.१२२,३९६.९५२,४२१.२२२,३८२.३२——
Q1 2026 earnings • in 2 days
See details
BNTX:NASDAQ
BioNTech SE - ADR
US$ ९७.५४
-५.७१%
(-५.९१) 1D
US$ ९७.५४
०.००% (०.००)
After hours
Closed: मे १, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BNTX...
Open
US$ ९८.४८
High
US$ ९९.०९
Low
US$ ९५.४२
Mkt. cap
२४.६७ अरब
Avg. vol.
१५.४३ लाख
Volume
१०.८३ लाख
52-wk high
US$ १२३.९८
52-wk low
US$ ७९.५२
EPS
-US$ ५.५१
Beta
१.५६
Shares outstanding
२५.२९ करोड
No. of employees
८ हजार
News stories
From sources across the web
Simply Wall Street
Simply Wall Street
·
१९ घण्टा पहिले
BioNTech Faces Tariff Risks And Leadership Shift As Oncology Plans Advance
TipRanks
TipRanks
·
२ दिन पहिले
Why BioNTech Stock Is Suddenly Sinking Today
Profile
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
About BioNTech SE - ADR
CEOUğur Şahin
Employees७.८१ हजार
Founded२००८
Headquarters-
Sector-
Websitebiontech.de
Next call २ दिनमा
मे ५, मङ्गल, ०८:००
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (-१.९२ est.)EUR
Revenue / Estimate
-/ (१५.५४ करोड est.)EUR
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
२०२५ मार्च
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
Revenue
१८.२८ करोड
२६.०८ करोड
१.५२ अरब
९०.७४ करोड
Cost of goods sold
८.३८ करोड
७.६४ करोड
१४.८३ करोड
३०.२८ करोड
Cost of revenue
८.३८ करोड
७.६४ करोड
१४.८३ करोड
३०.२८ करोड
Research and development expenses
५२.५६ करोड
५०.९१ करोड
५६.४८ करोड
५०.५४ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१२.०६ करोड
१३.७४ करोड
१४.८५ करोड
२१.७९ करोड
Operating expense
५९.३४ करोड
६२.११ करोड
१.४० अरब
९०.७२ करोड
Total operating expenses
६७.७२ करोड
६९.७५ करोड
१.५५ अरब
१.२१ अरब
Operating income
-४९.४४ करोड
-४३.६७ करोड
-३.३० करोड
-३०.२६ करोड
Other non operating income
१२.२६ करोड
१०.५४ करोड
९.६८ करोड
-१७.३८ करोड
EBT including unusual items
-४४.५४ करोड
-४०.२७ करोड
२.४७ करोड
-२२.७४ करोड
EBT excluding unusual items
-४१.९५ करोड
-३७.९३ करोड
४.०७ करोड
-२०.६५ करोड
Income tax expense
-२.९६ करोड
-१.६१ करोड
५.३४ करोड
७.७६ करोड
Effective tax rate
६.६५%
४.००%
२१६.१९%
-३४.१२%
Other operating expenses
-५.२८ करोड
-२.५४ करोड
६९.०३ करोड
१८.३९ करोड
Net income
-४१.५८ करोड
-३८.६६ करोड
-२.८७ करोड
-३०.५० करोड
Net profit margin
-२२७.४६%
-१४८.२४%
-१.८९%
-३३.६१%
Earnings per share
-१.७३
-१.६०
-०.१२
-०.३३
Interest and investment income
-
-
-
२६.५५ करोड
Interest expense
-७९.०० लाख
-६६.०० लाख
-२६.०० लाख
-
Net interest expenses
-७९.०० लाख
-६६.०० लाख
-२६.०० लाख
२६.५५ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
-४५.१६ करोड
-३८.५७ करोड
९.१२ करोड
-२६.७० करोड
Gain or loss from assets sale
-१.०० लाख
-३.०० लाख
-१३.०० लाख
-८.०० लाख
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer